SUPPORTIVE CARE OF CHILDREN WITH CANCER: PREVENTION AND TREATMENT OF CHEMOTHERAPY-INDUCED LIVER TOXICITY (SPECIFIC MODIFICATIONS OF CHEMOTHERAPEUTIC AGENTS WITH LIVER-DEPENDENT METABOLISM)
July 18th, 2011
A. Vincristine, vinblastine, and VP-16 (etoposide)Bilirubin 3.1 mg/dL or SGOT >180 U/mL: hold dose.B. Adriamycin, daunorubicin, idarubicin, and actinomycin-DBilirubin
A WORD ABOUT SOY INFANT FORMULAS – DESCRIPTION
June 29th, 2011
The humble soybean has had a meteoric rise to fame and fortune in Western countries during the last decade. Like any high profile rock star or movie idol, lots of media hype as well as several multi-million dollar marketing efforts have been essential to making this bean a household name. Making the soybean into a [...] pillwatch.com
RISK FACTORS FOR BREAST CANCER DEVELOPMENT
April 20th, 2011
About 1 out of 8 women will develop breast cancer at some time in her life. Although this oft-repeated ratio has frightened many women, it represents a woman’s lifetime risk. Thus, not until the age of 80 does a woman’s risk of breast cancer rise to 1 in 8. Here is the risk at earlier [...]
WHY DO WE GET SKIN CANCER?
January 31st, 2011
The common kinds of skin cancer (called basal cell cancers or squamous cell cancers) occur as a result of exposure of susceptible skin to ultraviolet light- Pigmentation protects the skin and so it is the fair-skinned races who tend to get these common kinds of skin cancer. Once skin has become pigmented as a result [...]
YOUR CANCER YOUR LIFE – PATTERNS OF SECONDARY GROWTH (PART 2)
May 12th, 2009
When cancer cells lodge in lymph nodes or other parts of the body, they don’t always immediately start multiplying to form an obvious secondary growth. Cancer cells have the ability to lie dormant, sometimes for many years. You could think of them as seeds which are waiting for the right conditions before they start growing. [...]